The features of choosing a drug for the initial therapy of iron-deficiency anemia in children
DOI: https://doi.org/10.29296/25877305-2019-05-04
Issue:
5
Year:
2019
The paper evaluates and compares the efficacy and toxicity of drugs based on iron (III)- hydroxide polymaltose complex and iron (II) sulfate given in standard doses for the treatment of iron-deficiency anemia in children.
Keywords:
hematology
iron-deficiency anemia
treatment
iron sulfate
iron-hydroxide polymaltose complex
efficacy
safety
undesirable events
children
oxidative stress
protein oxidative modification
References:
- Pasricha S., Black J., Muthayya S. et al. Determinants of Anemia Among Young Children in Rural India // Pediatrics. – 2010; 126 (1): e140–e149.
- Chang S., Wang L., Wang Y. et al. Iron-Deficiency Anemia in Infancy and Social Emotional Development in Preschool-Aged Chinese Children // Pediatrics. – 2011; 127 (4): e927–e933.
- Foote E., Sullivan K., Laird J. et al. Determinants of anemia among preschool children in rural, western Kenya // Am. J. Trop. Med. Hyg. – 2013; 88 (4): 757–64.
- Kuznik B.I., V.G. Sturov N.Ju. Levshin i dr. Gemorragicheskie i tromboticheskie zabolevanija i sindromy u detej i podrostkov: Patogenez, klinika, diagnostika, terapija i profilaktika. 2-e izd., pererab. i dop. / Novosibirsk: Nauka, 2018; 524 s. [Kuznik B.I., V.G. Sturov N.Yu. Levshin et al. Gemorragicheskie i tromboticheskie zabolevaniya i sindromy u detei i podrostkov: Patogenez, klinika, diagnostika, terapiya i profilaktika. 2-e izd., pererab. i dop. / Novosibirsk: Nauka, 2018; 524 s. (in Russ.)].
- Andreeva T.A., Zorenko V.Ju., Davydkin I.L. i dr. Effektivnost' i bezopasnost' preparata Oktofaktor v lechenii bol'nyh s tjazheloj i srednetjazheloj formoj gemofilii A (rezul'taty 2-j chasti klinicheskogo issledovanija II i III fazy) // Vopr. gematol. onkol. i immunopatol. v pediat. – 2013; 12 (4): 31–7 [Andreeva T.A., Zorenko V.Yu., Davydkin I.L. et al. Efficiency and safety of Octofactor in the treatment of patients with severe and moderate hemophilia A: Results of part 2 of phase II–III clinical trial // Vopr. gematol. onkol. i immunopatol. v pediat. – 2013; 12 (4): 31–7 (in Russ.)].
- Zaharova I.N., Machneva E.B. Korrektsija defitsita zheleza: istoricheskie i sovremennye aspekty // Voprosy prakticheskoj pediatrii. – 2014; 9 (4): 2–7 [Zakharova I.N., Machneva E.B. Correction of iron deficiency: background and current aspects // Voprosy prakticheskoi pediatrii. – 2014; 9 (4): 2–7 (in Russ.)].
- Gorodetskij V.V., Goduljan O.V. Zhelezodefitsitnye sostojanija i zhelezodefitsitnaja anemija: lechenie i diagnostika / M.: Medpraktika-M, 2008; 1–27 [Gorodetskii V.V., Godulyan O.V. Zhelezodefitsitnye sostoyaniya i zhelezodefitsitnaya anemiya: lechenie i diagnostika / M.: Medpraktika-M, 2008; 1–27 (in Russ.)].
- Powers J., Buchanan G., Adix L. et al. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia. A Randomized Clinical Trial // JAMA. – 2017; 317 (22): 2297–304.
- Haliotis F., Papanastasiou D. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children // Int. J. Clin. Pharmacol. Ther. – 1998; 36 (6): 320–5.
- Oral iron for Anemia: a review of the clinical effectiveness, cost-effectiveness and guidelines. Rapid response report. Summary with critical appraisal. Canadian Agency for Drugs and Technologies in Health. Available at: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0084957/pdf/PubMedHealth_PMH0084957.pdf
- Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview // Scientific World J. – 2012; 2012: 846824.
- Machneva E.B. Optimizatsija diagnostiki i kontrolja effektivnosti terapii zhelezodefitsitnyh sostojanij u detej. Avtoref. dis. ... kand. med. nauk. M., 2016; 25 s. [Machneva E.B. Optimizatsiya diagnostiki i kontrolya effektivnosti terapii zhelezodefitsitnykh sostoyanii u detei. Avtoref. dis. ... kand. med. nauk. M., 2016; 25 s. (in Russ.)].
- Jaber L., Rigler S., Taya A. et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy // J. Pediatr. Hematol. Oncol. – 2010; 32 (8): 585–8.
- Yasa B., Agaoglu L., Unuvar E. Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: a randomized trial in pediatric patients with iron deficiency anemia // Int. J. Pediatr. – 2011; 2011: Article ID 524520. http://dx.doi.org/10.1155/2011/524520.
- Kaneto H., Katakami N., Matsuhisa M. et al. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis // Mediators Inflamm. – 2010; 2010: 453892. DOI: 10.1155/2010/453892.
- Rodrigo R., González J., Paoletto F. The role of oxidative stress in the pathophysiology of hypertension // Hypertens Res. – 2011; 34 (4): 431–40. DOI: 10.1038/hr.2010.264.
- Darvesh A., Carroll R., Bishayee A. et al. Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents // Expert Rev. Neurother. – 2010; 10 (5): 729–45. DOI: 10.1586/ern.10.42.
- Giacco F., Brownlee M. Oxidative stress and diabetic complications // Circ. Res. – 2010; 107 (9): 1058–70.
- Kirilenko E.A., Onopko V.F. Okislitel'nyj stress i muzhskaja fertil'nost': sovremennyj vzgljad na problemu // Acta Biomedica Scientifica. – 2017; 2 (2): 102–8 [Kirilenko E.A., Onopko V.F. Oxidative stress and male fertility: modern view on the problem // Acta Biomedica Scientifica. – 2017; 2 (2): 102–8 (in Russ.)].
- Kennedy G., Spence V., McLaren M. et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms // Free Radical Biology and Medicine. – 2005; 39 (5): 584–9.
- Lebedev V.V., Demihov V.G., Fomina M.A. i dr. Metod kompleksnoj otsenki produktov okislitel'noj modifikatsii belkov dlja opredelenija bezopasnosti dvuh- i trehvalentnyh peroral'nyh preparatov zheleza i ih effektivnosti v lechenii zhelezodefitsitnoj anemii u detej // Pediatrija. – 2018; 97 (5): 47–53 [Lebedev V.V., Demikhov V.G., Fomina M.A. et al. A method for the complex evaluation of proteins oxidative modification products for determination of bivalent and trivalent oral iron preparations and their efficacy in iron deficiency anemia treatment in children // Pediatria. – 2018; 97 (5): 47–53 (in Russ.)].
- Mamaev A.N., Kudlaj D.A. Vizualizatsija dannyh v prezentatsijah, otchetah i issledovanijah / M.: Prakticheskaja meditsina, 2011; 39 s. [Mamaev A.N., Kudlai D.A. Vizualizatsiya dannykh v prezentatsiyakh, otchetakh i issledovaniyakh / M.: Prakticheskaya meditsina, 2011; 39 s. (in Russ.)].
- Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju zhelezodefitsitnoj anemii. Natsional'noe obschestvo detskih gematologov, onkologov / M., 2014 [Federal’nye klinicheskie rekomendatsii po diagnostiki i lecheniyu zhelezodefitsitnoi anemii, Natsional’noe obshchestvo detskikh gematologov, onkologov / M., 2014 (in Russ.)]. Rezhim dostupa / Available at: http://nodgo.org/sites/default/files/FKR%20po%20diagnostike%20i%20lecheniju%20zhelezodefitsitnoj%20anemii.pdf
- Fomina M.A., Abalenihina Ju.V., Fomina N.V. i dr. Sposob kompleksnoj otsenki soderzhanija produktov okislitel'noj modifikatsii belkov v tkanjah i biologicheskih zhidkostjah: metodicheskie rekomendatsii / Rjazan': RIORjazGMU, 2014; s. 36–9 [Fomina M.A., Abalenikhina Yu.V., Fomina N.V. et al. Sposob kompleksnoi otsenki soderzhaniya produktov okislitel’noi modifikatsii belkov v tkanyakh i biologicheskikh zhidkostyakh: metodicheskie rekomendatsii / Ryazan’: RIORyazGMU, 2014; s. 36–9 (in Russ.)].
- Dubinina E.E., Burmistrov S.O., Hodov D.A. i dr. Okislitel'naja modifikatsija belkov syvorotki krovi cheloveka, metod ee opredelenija // Voprosy meditsinskoj himii. – 1995; 41 (1): 24–6 [Dubinina E.E., Burmistrov S.O., Khodov D.A. i dr. Okislitel’naya modifikatsiya belkov syvorotki krovi cheloveka, metod ee opredeleniya // Voprosy meditsinskoi khimii. – 1995; 41 (1): 24–6 (in Russ.)].